Differin

What makes adapalene different starts with its skeleton. It is a naphthoic acid derivative built around an adamantyl cage — a rigid, lattice-like hydrocarbon — bolted to a methoxybenzene ring, and that bulky, stubborn architecture is the whole point. Earlier retinoids like tretinoin degrade in light and oxidize on contact with benzoyl peroxide, which is why patients were long told to layer them at separate times of day. Adapalene shrugs off both, staying chemically intact under UV and alongside benzoyl peroxide, the property that later made a single combination gel pharmacologically possible.

Its biology is also more targeted than the retinoids that preceded it. Rather than activating the full sweep of retinoic-acid receptors, it leans selectively on the beta and gamma subtypes, with its gamma activity doing most of the clinical work — block that receptor and the efficacy collapses, which is how researchers confirmed the mechanism. In the skin that translates to normalizing how keratinocytes proliferate and shed, unclogging the follicle before a comedone can form, which is why it earns its reputation as a first-line comedolytic rather than merely a spot treatment.

The molecule has had a quiet second life beyond acne, too. Investigators have probed it for plantar warts, molluscum, photoaging and even, in computational screens, as a possible viral entry inhibitor — a reminder that its receptor activity reaches past the pimple. Roughly a quarter is metabolized, mostly to glucuronides, with the rest excreted unchanged, a clean pharmacokinetic profile for a long-term topical.

The practical caveat is the one every retinoid carries: turnover gets visibly worse before it gets better, with weeks of dryness, flaking and a possible purge, and daily sunscreen is mandatory. Stubborn hormonal or cystic acne can still outrun it. But as a chemically elegant, generic-priced active with decades of trials behind it, it remains an unusually evidence-dense pick for a drugstore shelf.

Sources:[1][2][3]